Bioventix Plc BVXP
LSE · United Kingdom · Health Technology
GBp 1,640.00-60.00 (-3.53%)
Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
The United Kingdom's FTSE 100 index has recently faced downward pressure, largely influenced by weak trade data from China, highlighting challenges in global economic recovery. In such uncertain market conditions, dividend stocks can offer a degree of stability and income potential for investors seeking to navigate the volatility.
The United Kingdom's stock market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China and falling commodity prices affecting major companies. Amid these market fluctuations, dividend stocks can offer a measure of stability and income for investors seeking consistent returns. In this article, we will explore three UK dividend stocks, including B.P. Marsh & Partners, that may provide attractive opportunities in the current economic...
Whilst it may not be a huge deal, we thought it was good to see that the Bioventix PLC ( LON:BVXP ) CEO & Director...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.